Keybanc Maintains Overweight on Progyny, Lowers Price Target to $28
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $32 to $28.
Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $32 to $28.